The independence of SNAIL expression from conventional clinicopathological parameters, including tumor stage, grade, and molecular subtype, suggests it represents a fundamental characteristic of the metastatic stem cell phenotype rather than a secondary consequence of tumor progression. The gene discussed is SNAI1; the disease is neoplasm.